Dosing-time-dependent variation in biliary excretion of flomoxef in rats

被引:8
作者
Hishikawa, S
Sugimoto, K
Kobayashi, E
Kumagai, Y
Fujimura, A [1 ]
机构
[1] Jichi Med Sch, Dept Clin Pharmacol, Minami Kawachi, Tochigi 3290498, Japan
[2] Kitasato Univ, Dept Pharmacol, Sagamihara, Kanagawa 228, Japan
关键词
chronopharmacokinetics; circadian rhythm; flomoxef; antibiotic; biliary excretion; rats;
D O I
10.1081/CBI-120020421
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously reported that the biliary excretion of flomoxef, an oxacephem antibiotic, was greater after dosing at 21:00 than at 09:00h in diurnally active human subjects. The present study was undertaken, to examine whether the biliary excretion of flomoxef is also dependent on its dosing time in rats. Adult male Wistar rats were housed under light on at 07:00h and off at 19:00h. Bile fluid was completely drained through a polyethylene catheter from conscious animals. Flomoxef (20 mg/kg) was injected into the tail vein at 09:00 or 21:00h by a cross-over design, and drained bile fluid was collected for 8h after each dosing. The maximum concentration of biliary flomoxef was significantly greater and its total excretion tended to be greater after dosing at 09:00 than 21:00h. These results suggest the biliary excretion of flomoxef is enhanced after dosing at the beginning of the rest period in rats, as it is in humans.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [21] Biliary excretion of (51)chromium in bile-duct cannulated rats
    DavisWhitenack, ML
    Adeleye, BO
    Rolf, LL
    Stoecker, BJ
    NUTRITION RESEARCH, 1996, 16 (06) : 1009 - 1015
  • [22] Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats
    Ogawara, K
    Yoshida, M
    Furumoto, K
    Takakura, Y
    Hashida, M
    Higaki, K
    Kimura, T
    JOURNAL OF DRUG TARGETING, 1999, 7 (03) : 213 - +
  • [23] Biliary excretion of biotin and biotin metabolites is quantitatively minor in rats and pigs
    Zempleni, J
    Green, GM
    Spannagel, AW
    Mock, DM
    JOURNAL OF NUTRITION, 1997, 127 (08) : 1496 - 1500
  • [24] Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion
    Shin, Yong-Jun
    Lee, Joo Hyun
    Oh, Ju-Hee
    Lee, Young-Joo
    JOURNAL OF APPLIED TOXICOLOGY, 2013, 33 (06) : 511 - 515
  • [25] Dose-dependent absorption, metabolism, and excretion of genistein in rats
    Zhou, Siyuan
    Hu, Yuzhen
    Zhang, Bangle
    Teng, Zenghui
    Gan, Hongquan
    Yang, Zhifu
    Wang, Qingwei
    Huan, Menglei
    Mei, Qibing
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (18) : 8354 - 8359
  • [26] INCREASING INTAKES OF IRON REDUCE STATUS, ABSORPTION AND BILIARY-EXCRETION OF COPPER IN RATS
    YU, SG
    WEST, CE
    BEYNEN, AC
    BRITISH JOURNAL OF NUTRITION, 1994, 71 (06) : 887 - 895
  • [27] P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
    Zhang, Yan
    Wang, Changyuan
    Liu, Zhihao
    Meng, Qiang
    Huo, Xiaokui
    Liu, Qi
    Sun, Pengyuan
    Yang, Xiaobo
    Sun, Huijun
    Ma, Xiaodong
    Liu, Kexin
    PHARMACOLOGICAL REPORTS, 2018, 70 (02) : 243 - 250
  • [28] INDUCTION OF HEPATIC P-GLYCOPROTEIN ENHANCES BILIARY-EXCRETION OF VINCRISTINE IN RATS
    WATANABE, T
    SUZUKI, H
    SAWADA, Y
    NAITO, M
    TSURUO, T
    INABA, M
    HANANO, M
    SUGIYAMA, Y
    JOURNAL OF HEPATOLOGY, 1995, 23 (04) : 440 - 448
  • [29] P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
    Yan Zhang
    Changyuan Wang
    Zhihao Liu
    Qiang Meng
    Xiaokui Huo
    Qi Liu
    Pengyuan Sun
    Xiaobo Yang
    Huijun Sun
    Xiaodong Ma
    Kexin Liu
    Pharmacological Reports, 2018, 70 : 243 - 250
  • [30] Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment
    Cheng, Yaofeng
    Freeden, Chris
    Zhang, Yueping
    Abraham, Pamela
    Shen, Hong
    Wescott, Debra
    Humphreys, W. Griffith
    Gan, Jinping
    Lai, Yurong
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (05) : 276 - 286